Cameron Cowan is an expert in scientific computing and neuroscience with significant experience in ophthalmological research. Currently serving as the Head of Scientific Computing and Senior Researcher for Human Retinal Circuits at the Institute of Molecular and Clinical Ophthalmology Basel since July 2019, Cameron has made notable contributions by demonstrating synaptic transmission in human retinal organoids and investigating the effects of hypoxia on gene transcription in retinal cells. Prior to this role, Cameron was a Postdoctoral Fellow at the Friedrich Miescher Institute for Biomedical Research, where groundbreaking electrical recordings from post-mortem human retinas were achieved. Cameron's earlier research at Baylor College of Medicine focused on the neural pathways in retina function, accompanied by extensive training in various technical skills. Educational credentials include a PhD in Neuroscience from Baylor College of Medicine and a BS in Microbiology from The University of Texas at Austin.
This person is not in any teams
This person is not in any offices
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of vision, its diseases and to develop new therapies for vision loss. The institute is constituted as a foundation. IOB started operations in 2018. At IOB, we accelerate the conversion of basic research into innovative treatments which change the field of ophthalmic therapy. Interdisciplinary teams of researchers and clinicians work hand in hand. These problem-solvers and innovators have in-depth knowledge of unmet medical needs, and daily exposure to patients. Together, they improve the understanding of vision, and of the cells involved in eye disease. In this highly collaborative environment, IOB turns discoveries and technologies into clinical benefits for patients with blinding conditions. We help advance the practice of ophthalmic disease based on the genetic, structural and functional understanding of the cell types and their interactions within the human eye. At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of eye diseases and to develop new therapies for vision loss.